Williams, Ross D.
Reps, Jenna M.
Rijnbeek, Peter R.
Ryan, Patrick B.
Prieto-Alhambra, Daniel http://orcid.org/0000-0002-3950-6346
,
Funding for this research was provided by:
the innovative medicines initiative 2 joint (806968)
the european union’s horizon 2020
efpia
Article History
Received: 28 June 2021
Accepted: 4 November 2021
First Online: 6 December 2021
Declarations
:
: All authors have completed the ICMJE uniform disclosure form at ExternalRef removed and declare: AS, JW, JR, MvS and PBR are full-time employees of Janssen Research & Development, a pharmaceutical company of Johnson & Johnson, and shareholders in Johnson & Johnson. the Johnson & Johnson family of companies also includes DePuy Synthes, which is the maker of medical devices for joint reconstruction. DPA reports grants from Amgen, Grants from UCB Biopharma, grants from Les Laboratoires Servier, outside the submitted work. CO is a part-time employee of IQVIA.
: This article does not contain any studies with human participants or animals performed by any of the authors.